Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock
-
Total 13F shares
-
12,763,782
-
Share change
-
-2,072,291
-
Total reported value
-
$13,017,233
-
Price per share
-
$1.02
-
Number of holders
-
34
-
Value change
-
-$2,523,570
-
Number of buys
-
9
-
Number of sells
-
26
Institutional Holders of Vincerx Pharma, Inc. - Common Stock (VINC) as of Q4 2022
As of 31 Dec 2022,
Vincerx Pharma, Inc. - Common Stock (VINC) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,763,782 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, SAGE RHINO CAPITAL LLC, Affinity Asset Advisors, LLC, Long Focus Capital Management, LLC, Rock Springs Capital Management LP, CITADEL ADVISORS LLC, Schonfeld Strategic Advisors LLC, VANGUARD GROUP INC, SABBY MANAGEMENT, LLC, and Rubric Capital Management LP.
This page lists
34
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.